Physician profile
Jerome Edelson
NPI 1144683798
$6,289.48
in general payments reported to CMS, 2019-2025
13 companies · $628 in 2025
The $628 reported for 2025 was less than what a typical Gastroenterology (Internal Medicine) provider received nationally (typical 2025 total: $636).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $461 · 2021: $575 · 2022: $391 · 2023: $1,108 · 2024: $3,127 · 2025: $628.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $2,877 · Food and Beverage: $1,986.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $2,876.62 |
| Food and Beverage | $1,986.08 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Ovesco Endoscopy USA, INC. | $2,832.51 | 2024 | |
| Boston Scientific Corporation | $1,461.87 | 2023-2025 | Wallflex Duodenal, Axios, Overstitch Endoscopic Suturing System |
| Olympus America INC. | $869.67 | 2021-2025 | Single Use Electrosurgical Knife Kd-655, Single Use Aspiration Needle Na-U200h, Disposable Emr Kit |
| Abbvie INC. | $285.47 | 2019-2021 | |
| Medtronic, INC. | $148.48 | 2023 | Endoflip |
| Shire North American Group INC | $122.60 | 2019 | |
| Janssen Scientific Affairs, LLC | $121.90 | 2022 | |
| Gilead Sciences, INC. | $121.89 | 2019 | |
| Alexion Pharmaceuticals, INC. | $116.72 | 2021 | |
| E.R. Squibb & Sons, L.L.C. | $93.99 | 2021 | |
| Apollo Endosurgery US INC | $73.30 | 2022 | |
| Takeda Pharmaceuticals U.S.A., INC. | $20.88 | 2022 | |
| Astrazeneca Pharmaceuticals LP | $20.20 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jerome Edelson listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.